Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David F. Hale currently holds 3,300 shares of Dermata Therapeutics, Inc. (DRMA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David F. Hale has been a net seller of DRMA stock. They have purchased $405.8K and sold $777.9K worth of shares.
David F. Hale's most recent insider trade was on Jun 20, 2024, when they sold 3,300 shares at $0.00 per share.
David F. Hale serves as Executive at Dermata Therapeutics, Inc. (DRMA). They have executed 133 insider transactions totaling $1.2M over their tenure at the company.
David F. Hale holds the position of Executive at Dermata Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
David F. Hale has shown a selling trading pattern, with $405.8K in total purchases and $777.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David F. Hale was on Jan 2, 2014, when they sold $5.3M worth of SNTS shares. This transaction involved 164,713 shares at $32.00 per share.
David F. Hale currently owns 3,300 shares of Dermata Therapeutics, Inc. (DRMA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David F. Hale's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David F. Hale has 133 Form 4 filings on record as an insider at Dermata Therapeutics, Inc..
Set alerts for David F. Hale and 40,000+ other insiders.